Komori
A&D HOLON Holdings (7745) · RiskDropped

Intensifying competition in Russia's blood pressure monitor market

First written in FY2018-Q1. 6 of 14 entries say "Restated". Latest entry: FY2024.

14entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q1 – FY2018RestatedFY2019-Q2 – FY2020-Q3MitigatedFY2020 – FY2022-Q32017: 220172018: 420182019: 220192020: 220202021: 220212022: 120222023: 020232024: 12024
Same theme, other companies
Competition from Chinese companies entering Russia's blood pressure monitor marketA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2024DroppedAnnual report
    This filing does not contain a specific disclosure regarding intensifying competition in Russia's blood pressure monitor market.
  2. FY2022-Q3MitigatedAnnual report

    「In Europe, in Russia, the company won government tenders for blood pressure monitors and devoted substantial efforts to branding activities, including sponsoring various healthcare and wellness events. As a result, it increased its market share in a wide range of health equipment, including household blood pressure monitors.」

    In response to intensifying competition in Russia, the company reported increasing its market share in a wide range of health equipment by winning government tenders and conducting branding activities, including event sponsorships.
  3. FY2022-Q2MitigatedAnnual report

    「In Europe, in Russia, the company won government tenders for blood pressure monitors and devoted substantial efforts to branding activities, including sponsoring various healthcare and wellness events. As a result, it increased its market share in a wide range of health equipment, including household blood pressure monitors.」

    In response to the competitive environment in Russia's blood pressure monitor market, the company reported increasing its market share in a wide range of health equipment through winning government tenders and conducting branding activities.
  4. FY2021MitigatedAnnual report

    「In Russia, sales in local-currency terms increased as thermometers performed well in addition to blood pressure monitors, but sales in yen terms declined as the ruble weakened. Meanwhile, profit increased as the company worked to reduce expenses.」

    Although the burden of selling expenses against a backdrop of intensifying competition had previously been reported, the company reported increases in local-currency sales and profit for blood pressure monitors and thermometers in Russia during the year, along with improvement from cost reductions.
  5. FY2020MitigatedAnnual report

    「In Europe, both sales and profit increased, led by household blood pressure monitors in Russia.」

    Competition in Russia's blood pressure monitor market continued to intensify following the entry of competitors, but sales and profit both increased during the year, led by household blood pressure monitors. Conditions improved from the profit decline caused by higher advertising and promotional expenses through the previous year.
  6. FY2020-Q3Continued profit decline due to higher advertising and promotional expensesAnnual report

    「In Europe, sales increased, led by household blood pressure monitors in Russia, but profit declined because selling expenses also increased as a result of proactive advertising and promotional activities.」

    Sales of household blood pressure monitors in Russia increased, while selling expenses rose due to proactive advertising and promotional activities, including measures to address competition, resulting in lower profit.
  7. FY2019RestatedAnnual report

    「In Russia, competition in the blood pressure monitor market intensified following the entry of competitors, but sales increased as the company pursued proactive promotional activities. In addition, as the ruble showed signs of recovering against the yen, sales in yen terms increased substantially.」

    The company continued to counter intensifying competition in Russia's blood pressure monitor market through proactive promotional activities.
  8. FY2019-Q3RestatedAnnual report

    「In Europe, sales increased, particularly in Russia, but profit declined as the company actively conducted advertising and promotional activities to counter intensifying competition in the blood pressure monitor market following the entry of Chinese companies.」

    The company continued to report intensifying competition in Russia's blood pressure monitor market and lower profit due to advertising and promotional activities undertaken as a countermeasure.
  9. FY2019-Q2RestatedAnnual report

    「In Europe, sales increased in Russia, but profit declined as the company actively conducted advertising and promotional activities to counter intensifying competition in the blood pressure monitor market following the entry of Chinese companies.」

    The intensification of competition in Russia's blood pressure monitor market continued, as did the reported decline in profit resulting from advertising and promotional activities to counter it.
  10. FY2019-Q1MaterialisedAnnual report

    「In Europe, sales increased in Russia, but profit declined as the company actively conducted advertising and promotional activities to counter intensifying competition in the blood pressure monitor market following the entry of Chinese companies.」

    Advertising and promotional activities to counter intensifying competition in Russia's blood pressure monitor market resulted in an actual decline in profit.
  11. FY2018RestatedAnnual report

    「In Russia, competition in the blood pressure monitor market intensified following the entry of competitors, but sales increased as the company pursued proactive promotional activities. In addition, as the ruble showed signs of recovering against the yen, sales in yen terms increased substantially.」

    Competition in Russia's blood pressure monitor market continued to intensify, while sales increased due to proactive promotional activities and the ruble's recovery trend.
  12. FY2018-Q3RestatedAnnual report

    「In Europe, sales increased in Russia despite intensifying competition in the blood pressure monitor market following the entry of competitors. In addition, the Russian ruble appreciated against the yen, resulting in a substantial increase in yen-denominated sales.」

    Competition in Russia's blood pressure monitor market continued to intensify following the entry of competitors, while sales increased.
  13. FY2018-Q2RestatedAnnual report

    「In Europe, sales increased in Russia despite intensifying competition in the blood pressure monitor market following the entry of Chinese companies. In addition, the value of the Russian ruble rose against the yen, resulting in a substantial increase in yen-denominated sales.」

    Competition in Russia's blood pressure monitor market continued to intensify following the entry of Chinese companies, while sales increased.
  14. FY2018-Q1First statedAnnual report

    「In Europe, competition in Russia's blood pressure monitor market intensified following the entry of Chinese companies, but sales in local-currency terms remained broadly at the level of the same period of the previous year.」

    The entry of Chinese companies and resulting intensification of competition in Russia's blood pressure monitor market were identified for the first time as a specific market risk.
Moved together

"Stabilizing Earnings by Reviewing the Sales Structure for Measurement Instruments in the Americas" moved the same way as this thread, in the same document, in 4 of its 14 moves.

444222★123456
  1. ★This thread
  2. 1Stabilizing Earnings by Reviewing the Sales Structure for Measurement Instruments in the Americas4×
  3. 2Reducing Development Costs and Inventories and Improving Profitability4×
  4. 3Dependence on Borrowings and Interest-Bearing Debt and the Challenge of Reducing It4×
  5. 4Research and development investment based on measurement technology2×
  6. 5Differentiation through investment in new products, new markets and growth areas2×
  7. 6Entry into and Expansion of the Industrial Measurement Equipment Business2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
A&D HOLON Holdings's next results are scheduled for 2026-11-06. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Intensifying competition in Russia's blood pressure monitor market | A&D HOLON Holdings Company,Limited (7745) | Komori